Aeterna Zentaris : Audited Consolidated Financial Statements of Ceapro Inc as of December 31, 2023 and 2022 and for the years ended December 31, 2023 and 2022 - Form 6-K marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
TORONTO and EDMONTON, Alberta, March 12, 2024 Aeterna Zentaris Inc. and Ceapro Inc. are pleased to announce that securityholders of both biopharmaceutical development companies approved the.
Aeterna Zentaris Inc. ("Aeterna") and Ceapro Inc. ("Ceapro") are pleased to announce that securityholders of both biopharmaceutical development companies approved the all-stock merger of equals transaction (the "Transaction") at their respective.
EDMONTON, Alberta, June 07, 2023 Ceapro Inc. , a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic. | June 7, 2023